Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
Background Patients receiving hematopoietic stem cell transplantation (HSCT) or chimeric
antigen receptor T cell (CAR T-cell) therapy are immunocompromised and at high risk of …
antigen receptor T cell (CAR T-cell) therapy are immunocompromised and at high risk of …
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an …
N Uaprasert, P Pitakkitnukun… - Blood Cancer …, 2022 - nature.com
Patients with hematologic malignancies (HM) have demonstrated impaired immune
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity …
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
Immunogenicity of SARS-CoV-2 vaccination is diminished in hematopoietic stem cell
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients
J Zaleska, P Kwasnik, M Paziewska… - … Journal of Cancer, 2023 - Wiley Online Library
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) patients have increased
morbidity and mortality rates of COVID‐19 due to immunosuppression associated with the …
morbidity and mortality rates of COVID‐19 due to immunosuppression associated with the …
[HTML][HTML] Predictors of COVID-19 vaccination response after in-vivo T-cell–depleted stem cell transplantation
O Chaekal, A Gomez-Arteaga, Z Chen, R Soave… - … and Cellular Therapy, 2022 - Elsevier
Covid-19 vaccination is recommended in allogeneic transplant recipients, but many
questions remain regarding its efficacy. Here we studied serologic responses in 145 patients …
questions remain regarding its efficacy. Here we studied serologic responses in 145 patients …
Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic …
M Barkhordar, B Chahardouli, A Biglari… - Frontiers in …, 2023 - frontiersin.org
Background Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients must be
vaccinated against SARS-CoV-2 as quickly as possible after transplantation. The difficulty in …
vaccinated against SARS-CoV-2 as quickly as possible after transplantation. The difficulty in …
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation
ML Hütter-Krönke, A Neagoie, IW Blau, V Wais… - Frontiers in …, 2023 - frontiersin.org
Introduction Vaccination against severe acute respiratory syndrome coronavirus type 2
(SARS-CoV-2) is approved and recommended for immunocompromised patients such as …
(SARS-CoV-2) is approved and recommended for immunocompromised patients such as …
Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized …
Background/Purpose Optimizing vaccine efficacy is of particular concern in patients
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: an observational …
M Nishikubo, Y Shimomura, H Maruoka, S Nasu… - Journal of Infection and …, 2023 - Elsevier
Background The effectiveness of mRNA COVID-19 vaccines and the optimal timing of
vaccine administration in allogeneic hematopoietic stem cell transplantation (Allo-HSCT) …
vaccine administration in allogeneic hematopoietic stem cell transplantation (Allo-HSCT) …
SARS-CoV-2 vaccine-induced immune responses among hematopoietic stem cell transplant recipients
Background Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination reduces the risk and severity of coronavirus disease 2019 (COVID-19), several …
vaccination reduces the risk and severity of coronavirus disease 2019 (COVID-19), several …